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CAMP factor is an extracellular pore-forming toxin secreted by the group B streptococci 
Streptococcus agalactiae.  In conjunction with the action of sphingomyelinase secreted 
by Staphylococcus aureus, which converts membrane sphingomyline to ceramide, CAMP 
factor kills susceptible cells by creating holes in them. 
 Since the monomeric or oligomeric structure of CAMP factor is not yet known, 
no studies on the membrane-penetrating domain of this toxin have been done.  In the 
present study, the interaction of a putative hydrophobic domain between residues T90 
and V115 with the target membrane was examined by cysteine-scanning mutagenesis and 
site-selective fluorescent labeling. 
The combination of steady state and lifetime fluorescence measurements and 
collisional quenching experiments with nitroxide labeled fatty acids indicate that residues 
from T90 to V115 contact the membrane upon binding and oligomerization of CAMP 
factor on cell membranes.  More importantly, all these individual assays indicate that the 
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CAMP factor is an extra-cellular protein secreted by group B streptococci (GBS) 
or Streptococcus agalactiae, with a pI of 8.6 and a molecular mass of 25kDa.  
Streptococcus agalactiae is a major cause of mastitis in dairy cattle and a source of 
economic loss for the industry (1).  S. agalactiae also causes neonatal septicemia in 
humans.  Human infection is generally acquired from other human sources, although 
there may be some risk associated with direct exposure to infected animals or their 
products.  Overall, there is considerable homology between strains isolated from 
septicemic infants and mastitic cows (1).  Streptococcus agalactiae is now recognized to 
be part of the normal bacterial flora in the human throat, genitourinary tract, and rectum 
(1). 
 When grown on sheep blood agar plates next to a colony of Staphylococcus 
aureus, Streptococcus agalactiae induces a hemolytic phenomenon.  This phenomenon 
was first described in 1944 by Christie, Atkins and Munch-Petersen, and thus named the 
CAMP reaction (2).   
The CAMP reaction is widely used for the presumptive identification of 
Streptococcus agalactiae in clinical isolates.  Typically, a nutrient sheep blood agar plate 
is used in this procedure (1).  A strain of Staphylococcus aureus that produces 
sphingomyelinase (also known as β-hemolysin), and the putative isolates of S. agalactiae 
are streaked across a plate at right angles, close to but not touching each other.  If CAMP 
factor is present, a distinct zone of hemolysis develops in the adjoining area of the two 





Figure 1.1: CAMP reaction. A blood agar plate is shown after 24 hours of incubation at 
37°C. The vertical streak is a β-hemolysin-producing strain of Staphylococcus aureus, 
and at right angles to it are streaks of (1) Enterococcus faecalis, (2) Streptococcus 
salivarius, (3) Streptococcus agalactiae, and (4) Enterococcus durans. Note the large 
area of complete hemolysis where the extracellular compound of S. agalactiae encounters 
the β-hemolysin of S. aureus (3). 
 
Bernheimer et al. were the first to intensively explore the nature and mechanism of the 
CAMP reaction.  They purified CAMP factor from bacterial culture supernatants and 
determined the pI and molecular weight (4).  They also pointed out the role of 
sphingomyelinase in the CAMP reaction, and the sequential nature of the latter (4). In the 
first step, sphingomyelin in the sheep red blood cell membranes is converted to ceramide 
(figure 1.2) by sphingomyelinase from Staphylococcus aureus.  CAMP factor then binds 












































Figure 1.2: The reactions catalyzed by sphingomyelinase and phospholipase C. 
 
Christie, Fehrenbach and co-workers reported that CAMP factor may cause lysis 
of red blood cells that contain at least 45 mol% of sphingomyelin in the cell membrane 
(5), (6).  They demonstrated that sphingomyelinase-treated sheep and bovine erythrocytes, 
which contain 50 and 45 mol% of sphingomyelin respectively, are susceptible to CAMP 
factor; in contrast, human, horse, or rabbit erythrocytes, which contain less than 25 mol% 
sphingomyelin, are not susceptible (7).   However, when human and rabbit erythrocytes 
were treated with phospholipase C, which will convert the glycerophospholipids to 
diacylglycerol (figure 1.2), the CAMP reaction could be observed (8).  These results 
demonstrated that ceramide was not specifically required for the CAMP reaction.  By 
using artificial membranes (liposomes), Fehrenbach and co-workers also showed that the 
cholesterol content in the target membrane was critical to CAMP factor activity (6), (8). 
 CAMP factor is a cysteine-free protein with two methionine residues.  For the 
purpose of this study, the two methionine residues were substituted with leucine, forming 
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the double mutant CAMP
M21L,M107L
, which was expressed as a 52 kDa glutathione-S-
transferase fusion protein in E. coli.  The fusion protein was purified to homogeneity 
using affinity chromatography and cleaved by thrombin to yield the recombinant 25 kDa 
CAMP factor protein.  The resulting recombinant protein was shown to possess similar 
hemolytic activity to the native protein. 
 
1.1 CAMP Factor is a Pore-Forming Toxin 
 The CAMP reaction shown above establishes that CAMP factor causes lysis of 
sphingomyelinase-treated sheep red blood cells. However, what is its mode of action?  
Electron microscopy and osmotic protection experiments using polyethylene glycol (PEG) 
by S. Lang and M. Palmer showed that CAMP factor forms pores of heterogeneous size 
on red blood cells (9).  These pores are tiny holes admitting passage of liquids or ions, 
and while most of the pores created by CAMP factor are very small and sometimes hard 
to distinguish from the background, some pores are larger than 12 nm and with regular 





Figure 1.3: An electron micrograph of the pores on red blood cells.  The pores range in 
sizes depending on the toxin concentration (9).  Magnification varies among panels A-D 
by the scale bars. 
 
In the osmotic protection experiments, there was a considerable delay of 
hemolysis in the presence of PEG 6000 and PEG 8000.  Hemolysis was even much 
slower with PEG 10000.  In contrast, PEG 1000 and PEG 4000 had no protective effect 
on CAMP factor-mediated hemolysis.  When cells were incubated with CAMP factor in 
the presence of PEG 10000, washed twice in the same buffer to remove unbound protein, 
and re-suspended in buffer without PEG, hemolysis occurred immediately.  This 
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confirmed that pore-formation had indeed proceeded in the presence of PEG, indicating 
that PEG had effected osmotic protection, but had not directly inhibited the binding or 
hemolytic action of CAMP factor.  These data indicate that CAMP factor forms pores 
with a defined diameter on susceptible membranes (9). 
 
1.2 Pore-Forming Toxins (PFTs) 
The above experiments confirm the pore-forming characteristics of CAMP factor.  
Proteins and peptides with pore-forming activities are found in a variety of organisms 
such as bacteria, plants, fungi, primitive metazoans, insects and humans (10).  Not all 
pore-forming proteins produced by these organisms are toxins however, and for the 
purpose of this study, only the toxins will be considered.  Pore-forming toxins are mostly 
produced as water-soluble molecules destined to form pores in the lipid membranes of 
the host organism.  They interact with cell or artificial lipid membranes, change 
conformation and oligomerize in the plane of the membrane to build water-filled pores 
that are permeable to solutes (11), figure 1.4.   
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Pore formation causes osmotic imbalance, which subsequently leads to cell 
swelling, lysis and death (12).  It has emerged as a major and widespread mechanism for 
cell destruction in bacteria, plants, fungi, insects and animals (13). 
Although most of these proteins are virulence factors, they are also used by cell 
biologists as tools for controlled permeabilization of cell membranes.  In this application, 
they are usually superior to other membrane-permeabilizing agents such as digitonin or 
saponin, since the effects of the latter are normally difficult to predict, control or monitor 
(14).  Detergents such as digitonin and saponin can only be applied in a narrow range of 
time and concentrations (15) and their use harbors the hazards of incurring direct damage 




Pore-forming toxins can also be designed to be expressed and exert their lethal 
effects on cancer cells.  For example, Yang et al., investigated the effects of streptolysin 
O (SLO) on 293T cancer cells.  They found that SLO attacks membranes and does not 
require any assistance from cellular proteins for its lethal attack, so there is little chance 
of the cell acquiring resistance by changing the expression levels of cellular proteins (17). 
Other beneficial use of pore-forming toxins is in the control of pests.  There are 
growing public concerns regarding the use of chemical insecticides.  This has led to the 
extensive use of environment-friendly alternatives, of which the Bacillus thuringiensis δ-
endotoxins are the main choice of the insect bio-control market (18).  These toxins are 
highly specific to their insects, are innocuous to humans, vertebrates and plants and are 
completely biodegradable.  Therefore, Bacillus thuringiensis is a viable alternative for the 
control of insect pests in agriculture and of important human disease vectors (18), (19). 
 
1.3  Structural Classification of Pore-Forming Toxins 
 Bacterial pore-forming toxins (PFTs) can be broadly classified into two groups: 
Those that interact with the membrane through α helices, and those that utilize mostly β 
sheet structures such as β barrels (11).  While the β-sheet interacting bacterial toxins (β-
PFTs for short) include α-hemolysin from Staphylococus aureus and aerolysin from 
Aeromonas hydrophila, the helical (or α-PFT) family includes Bacillus thuringiensis δ 
endotoxins, and bacteriocins such as colicin Ia of Escherichia coli (20), (21).   
The B. thuringiensis δ endotoxins are agriculturally important insecticidal agents (11) as 
mentioned above, which are thought to act through oligomerization (21).  Colicins 
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secreted by Escherichia coli are agents of bacterial ‘warfare’ that kill sensitive strains of 
E. coli (11).    
The conformation of the pores formed by the CAMP factor toxin, the monomeric 
or oligomeric structure and the molecular mechanism of CAMP factor toxin interaction 
with and insertion into membranes are still unknown. Known, however, is the relatively 
high percentage of α-helical content - approximately 30% as determined from the CD 
spectrum (9).  This analysis also indicates about 19% β-strands, 22% turns and 29% 
random coil in the CAMP protein (9). 
 
1.4 Membrane Interactions of α- and β-PFTs 
Pore-forming toxins bind, oligomerize, then insert into the lipid bilayer. 
Membrane insertion requires a conformational change that exposes one or more 
hydrophobic structures hidden in the water-soluble monomer.  These hydrophobic 
residues then insert into the membrane, forming the active pore. 
 Most pore-forming toxins studied to date do not contain extended hydrophobic 
sequences. The membrane-inserting domains of β-PFTs such as Staphylococcus aureus 
α-toxin, perfringolysin O and other cholesterol-dependent cytolysins, and anthrax toxin 
protective antigen consist of amphipathic sequences that, upon toxin oligomerization, 
interact with each other and form a membrane-inserted β-barrel, which surrounds the 
lumen of the pore (22).  In the β-barrel, the β-hairpins are arranged in such a way that 
their hydrophilic residues are oriented towards the lumen, while the intervening 
hydrophobic residues face the membrane lipids (22), (23). 
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 α-PFTs such as the pore-forming colicins and diphtheria toxin on the other hand 
contain hydrophobic and amphipathic α-helices long enough to span a lipid membrane 
(22).  The hydrophobic α-helices are thereby buried within the toxin as long as it is in its 
water-soluble form (22).  However, on the target membrane, partial unfolding of the toxin 
leads to a change in toxin conformation and insertion of the hydrophobic (and likely of 
amphipathic) α-helices as α-helical hairpins into the membrane, resulting in the 
generation of a transmembrane pore (22). 
 
1.5 Alpha Pore Forming Toxins  
The δ-endotoxins from Bacillus thuringiensis (B.t.) are insecticidal proteins that 
kill by forming pores in the epithelial cell membrane of some insect midgut (24).  These 
toxins form crystalline parasporal inclusions and are ingested by insects, subsequently 
dissolving under the alkaline and reducing conditions in the midgut, whereupon cleavage 
by the gut proteases converts the protoxin to the active toxin (24).  The activated toxin 
binds to the epithelial surface and causes pore formation in the cell membrane (24).  The 
subsequent osmotic swelling and cell lysis result in cessation of feeding and breach of the 
gut-haemocoel barrier, killing the insect through starvation and septicaemia (24).   
The δ-endotoxins form two multigenic families, cry and cyt (25).  Members of the 
cry family are specifically toxic to insects in the three orders of Lepidoptera, Diptera and 
Coleoptera, due to their requirement for specific binding proteins (receptors) that are 
present on the midgut epithelial cell membranes (26).  On the other hand, the cyt δ-
endotoxins are specifically lethal to the larvae of Diptera insects (27). including the 
Anopheles and Simulium species that function as vectors for malaria and river blindness, 
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respectively (28), (29), (30).  Although the class of α-PFTs contains many major 
virulence factors, the pore structures and even oligomeric stoichiometries of members of 
this family are still poorly characterized. This is because the oligomers aren’t stable, thus, 
can’t be extracted from membranes and characterized. 
 
1.6 β-Pore-Forming Toxins 
 In contrast, the insertion pathways and pore structures of β-PFTs are much better 
understood.  Like α-PFTs, β-PFTs are released as soluble monomers.  β-PFTs 
oligomerize before forming active pores.  The final insertion step often requires 
significant rearrangement of part of the structure, so that subunits can donate β-strands to 
form a trans-membrane β-barrel.  For example, the pores formed by several 
Staphylococcus aureus toxins are well characterized.  This applies to α-hemolysin (α-HL), 
which forms heptameric pores (figure 1.4 A), and to the leukocidins, which form hetero-











A                                                                                                B 
 
C                                                                         D 
 
Figure 1.5: Structures of β-pore forming toxins. (A) α-HL subunit in the pore state, (B) 
LukF monomer, (C) LukS monomer, (D) aerolysin monomer. The regions that form the β 
-hairpins that insert into the membrane are coloured in red (31). 
 
 
Most of the β-PFT such as aerolysin from Aeromonas hydrophila and α-HL 
oligomerize into a non-lytic pre-pore (a state where the toxin has oligomerized without its 
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trans-membrane domain inserted into the membrane) state on the membrane surface prior 
to insertion.  After this step, insertion occurs, leading to the pore form.  This pre-pore 
state is a common feature of other β-PFTs and has been trapped with suitably engineered 
disulfide bonds in Staphylococcal α-hemolysin (32).  The conformational changes that 
occur during membrane insertion have been identified by comparing the monomeric 
structures from the bi-component leukocidin system with the pore state of α-HL (33).  
The hemolysin subunit has three domains – the cap, rim and stem domains - with mainly 
β-structure.  In the water-soluble state, the stem domain is folded against the monomer 
core (34).  To form the distinctive mushroom shape of the pore, the stem domains flip out 
















A                                                                         B 
 
C                                                                                D 
 
 
Figure 1.6: Oligomeric toxin structures. The α-HL pore viewed (A) from the side and (B) 
from the membrane. The β-barrel is formed from the β-hairpins.  The hairpin-forming 
loop of anthrax protective antigen packs between subunits in the pre-pore state, as shown 
(C) from the side and (D) from the membrane (31). 
 
 Other well-characterized β-PFTs include aerolysin from Aeromonas hydrophila 
(figure 1.4 D), and the cholesterol-binding toxins (CBTs) produced by various gram-
positive bacterial genera (11).  CBTs contrast strongly with these other toxins in forming 
large ring- and arc-shaped oligomers with up to 50 subunits (11). 
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 Structurally and functionally related CBTs (also know as thiol-activated toxins 
and cholesterol-dependent cytolysins) have been identified in five bacterial genera: 
Streptococcus, Listeria, Bacillus, Clostridium, and Arcanobacterium (11).  A number of 
reviews have appeared on CBTs, including those by Gilbert (11), Alouf and Geoffroy (22) 
and Tweten (35). 
The prerequisite for a CBT to attack a membrane is the presence of cholesterol in 
the membrane (11).  Solving the X-ray crystal structure of a CBT (perfringolysin) 
revealed that it has an elongated, four-domain structure (11).  The N-terminal 75% of the 
molecule contains three domains, with the polypeptide chain passing backwards and 
forward between them; the fourth, C-terminal domain has an immunoglobulin type fold 








Figure 1.7: A view of the perfrinoglysin monomer solved by X-ray crystallography. The 
regions of domain 3 involved in pore formation are shown in red. The hook-shaped loop 
in domain 4 is involved in binding events.  
  
 
1.7 “A-B” toxins  
 The principle of pore-formation also occurs in a class of toxins that are known as 
the “A-B toxins”. In these toxins, trans-membrane pores function as transporters for 
enzymatic toxin moieties that, once delivered to the cytosol of the target cell, will cause 
cell death (37).  Examples include cholera, ricin, diphtheria, tetanus, and anthrax toxins.  
Gill (38) named these “A-B toxins”: the “A” portion is the active, enzymatic part of the 
toxin, and the “B” portion is the part of the toxin that binds to the cell membrane and 






The B portion of these toxins make pores in planar lipid bilayers (39) and  may 
adopt primarily beta transmembrane structure (anthrax, cholera toxins) or alpha 
transmembrane structure (colicin E, Bt, diphtheria toxins).  Mutants that are defective in 
pore formation are also defective in poisoning cells (40).  Diphtheria toxin (DT) secreted 
by Corynebacterium diphtheriae is a member of this A-B family of toxins.  After 
proteolytic processing, the toxin consists of two polypeptide chains, A (21 kDa) and B 
(37 kDa), that are joined by a disulfide bond (41).  The A chain is identical to the 
catalytic (C) domain of the protein, while the B chain consists of two domains, the 
receptor binding domain (R) and the transmembrane (T) domain (41).  After entry into 
endosomes via receptor-mediated endocytosis, a conformational change triggered by the 
low pH of the endosomal lumen renders the toxin hydrophobic (42).  This allows the 
toxin to penetrate the endosomal membrane and translocate its A chain into the cytosol.  
The final release of the A chain may follow reduction of the disulfide linking it to the T 
domain, perhaps with the aid of cytosolic proteins (41).  Once in the cytosol, the A chain 
catalyzes the ADP-ribosylation of the diphthamide residue of elongation factor 2, which 
inhibits protein synthesis and leads to cell death (43) (41). 
 
1.8 Membrane Interactions of α-Pore-Forming Toxins 
 The membrane interactions of the δ-endotoxin Cry will be discussed as a model 
for α pore forming toxins.  The tertiary structures of six different three-domain Cry 
proteins, Cry 1Aa, Cry2Aa, Cry 3Aa, Cry 3Bb, Cry 4Aa and Cry 4Ba have been 
determined by X-ray crystallography (19), (30) (figure 1.7). 
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Figure 1.8: Structure of (A) the monomeric δ-endotoxin Cry 3Bb1 and (B) the Diphtheria 
toxin and (C) equinatoxin II.  The membrane inserting regions are coloured in red. 
 
All these structures display a high degree of similarity with a three-domain organization, 
suggesting a similar mode of action of the Cry three-domain protein family (19).  The N-
terminal domain (domain I) is a bundle of seven α-helices in which the central helix-α5 is 
hydrophobic and is encircled by six other amphipathic helices; and this helical domain is 
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responsible for membrane insertion and pore-formation (19) (figure 1.7).  Domain II 
consists of three antiparallel β-sheets with exposed loop regions, and domain III is a β-
sandwich (30), (19).  Exposed regions in domains II and III are involved in receptor 
binding (19).  Domain I shares structural similarities with other PFTs like colicin Ia and 
N and diphtheria toxin (figure 1.7), supporting the role of this domain in pore-formation 
(19).  In the case of domain II, structural similarities with several carbohydrate-binding 
proteins like vitellin, lectins (class of carbohydrate-binding proteins), jacalin, and lectin 
Mpa have been reported (44).  Domain III shares structural similarities with other 
carbohydrate-binding proteins and these similarities suggest that carbohydrate moieties 
could have an important role in the mode of action of three-domain Cry toxins (19).  
Interestingly, in the nematode Caenorhabditis elegans, mutations in bree genes involved 
in the synthesis of certain glycolipids lead to Cry5 resistance, suggesting that glycolipids 
may function as receptor molecules of Cry5 (45).   
So far we’ve only been discussing pore forming proteins in the form of bacterial 
toxins; however, there also exist non bacterial pore-forming toxins such as the eukaryotic 
pore-forming toxin equinatoxin II from sea anemones, a representative of actinoporins 
(46) (figure 1.7).  The membrane topology of this α-helix pore forming toxin and others 
such as diphtheria toxin, have been studied using different spectroscopic assays.  These 
assays include cysteine scanning mutagenesis where BODIPY labeled with streptavidin 
was used to assay the accessibility of biotin attached to residues on diphtheria toxin (47) 
and IANBD labeling followed by hydrophilic quenching to study the N-terminus of 
equinatoxin (46).   In the case of diphtheria toxin, the T domain has been observed to 
exist in two distinct conformations, shallowly and deeply inserted states (48).  Just like 
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the diphtheria toxin, Equinatoxin II also shows these two states (46).  Upon membrane 
insertion, variations in the behaviour of these toxins were detected every 3-4 amino acid 
residues (46) suggesting an alpha helical conformation. 
 
1.9  Membrane Insertion Pattern of β-Pore-Forming Toxins 
To determine directly how a particular residue interacts with cell membranes in 
membrane-bound PFT oligomers, that residue is replaced by a cysteine residue and 
covalently modified or bound to an environmentally sensitive fluorophore (49).  This 
approach requires an otherwise cysteine-free protein.  The spectral properties of the 
fluorescent label are then determined before and after it is bound to the membrane.  N,N-
dimethyl-N-(iodoacetyl)-N-(7-nitrobenz-2-oxa-1,3-diazolyl)-ethylenediamine (IANBD) 
has been the fluorophore of choice for many studies, because its emission intensity and 
lifetime both increase substantially upon moving from an aqueous solvent into the 
hydrophobic interior of the bilayer (50). 
  As seen in figure 1.8, if the toxin polypeptide spans the membrane in a β-sheet 
conformation, as does Perfringolysin O (PFO) from Clostridium perfringens, (50), then 
one would expect the environment of residues along the membrane-bound polypeptide to 




Figure 1.9: Membrane Binding-Dependent Fluorescence Changes of NBD Probes 
Located at Sites within TMH2.  The emission intensity of a NBD-labeled PFO mutant 
was determined at 25 °C (Fsoluble) and then liposomes were added and incubated (37 °C, 
10 min) before the emission intensity of the membrane-bound PFO was measured at 25 
°C (Fmemb).  The ratio of these two values indicate the extent of change of NBD 
environment upon binding to the membrane (a high ratio occurs when NBD moves from 
an aqueous to a nonpolar milieu) (49). 
 
 Alternatively, if the PFO inserts into the bilayer as an amphipathic α-helix, as proposed 
for SLO (50) then the periodicity of residues facing the aqueous pore or the nonpolar 
bilayer should conform to a helical wheel analysis of the residues in the α-helix (50). 
When these membrane-permeabilizing toxins interact with membranes, a portion 
of the toxin/protein polypeptide will span the bilayer and form the interface between the 
aqueous channel and the non-polar core of the bilayer, in turn, forming pores.  Structures 
of these membrane permeabilizing toxins are usually used to predict the transmembrane 
domains and then confirmed using techniques such as cysteine scanning mutagenesis and 





1.10 Modification of Cysteine  
Chemical modification of amino acids is very important for the attachment of 
external probes such as fluorophores, to study the behaviour of proteins (50).  Amino 
acids with amine, sulfhydryl, imidazol and carboxyl groups can all be covalently and 
selectively modified (51).  Lysine residues can be selectively derivatized by a number of 
reagents, such as succinic anhydride and N-hydroxysuccinimide derivatives. However, 
the high frequency of occurrence of lysine residues in proteins makes it unfeasible to 
selectively modify a single residue. Although the histidyl side chain can react with 
halides and diethyl-pyrocarbonate, histidine residues are often critical for the biological 
activities of proteins and thus it is impractical to modify them (51).   
Due to its relatively rare occurrence and possession of the strongest 
nucleophilicity among all standard amino acids, cysteine is the most convenient target for 
specific modification with various reagents (52). Site-directed mutagenesis makes it 
possible to place cysteine residues at defined positions in protein, and subsequently 
modify them with fluorescent probes. This is done for each amino acid residue in a region 
of interest in a strategy known as ‘cysteine scanning mutagenesis’. This procedure has 
enabled mapping the topology of membrane proteins and the secondary structure of 
membrane-spanning regions in membrane proteins (52).  Also, labelling cysteine mutants 
with reagents of different sizes and charges may result in a functionally altered protein, 
which will provide valuable information on its mechanism of action.  As shown in figure 
1.9, the sulfhydryl group of cysteine reacts with alkylating reagents such as 
haloacetamides and maleimides to form chemically stable products.  
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Iodoacetamide derivatives are the most commonly used reagents for attaching 
structural probes to cysteine residues. Examples of such reagents are N, N'-dimethyl-N- 
(iodoacetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)ethylenediamine (IANBD amide), N-
iodoacetyl-N-(5-sulfo-1-naphthyl)ethylenediamine (1,5-IAEDANS), and 5-
iodoacetamido-fluorescein. Iodoacetate esters also are occasionally used for introducing 
structural probes and preparing bio-conjugates. Examples include IANBD ester, and 
iodoacetate biotin derivatives.  
Maleimide reacts rapidly with excellent specificity with cysteines in proteins. The 
reaction of N-ethylmaleimide with sulfhydryl groups can be monitored quantitatively by 
spectrophotometry (52). N-Ethylmaleimide has a maximum absorbance at 305 nm. Upon 
formation of the cysteine-maleimide adduct, the absorbance decreases in proportion to 
the extent of reaction. Maleimides hydrolyze in aqueous solution to non-reactive 
maleamic acids; in fact, the competition between cysteine modification and maleimide 
hydrolysis can be a serious problem at pH above 8 (51). There is a large collection of 
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Figure 1.10: A, Structures of some of the dyes used in cysteine scanning mutagenesis. B, 




Insights regarding the structure of the pore-forming domain of CAMP factor 
within the membrane could significantly advance understanding of the mode of action of 
this toxin.  Since CAMP factor is not homologous to any other toxin, its functional 
properties cannot be predicted based on similarities, so it is justified to study it 
experimentally. 
Therefore, a hydropathy analysis of the toxin was performed by a previous MSc. 
student, Shanshan Liu, which provided a hydropathy plot of S. agalactiae’s CAMP factor, 
identifying a hydrophobic region from amino acid T90 to V115.  Using cysteine scanning 
mutagenesis and site specific labeling of mutants S101, G110, I111, T112, K113, and 
V115, she showed that these residues contact the membrane upon toxin binding and 
oligomerization on sphingomyelinase treated sheep red blood cells.  In this study, 
mutants between residues T90 and V115 excluding those mentioned above were studied 
using cysteine scanning mutagenesis and site specific fluorescent labeling.  Spectroscopic 
and lifetime analysis of these labeled mutants in solution and on membranes indicate that 
this region, T90 to V115, inserts into the membrane, and that residues N104 to F109 








2.0 Experimental Procedures 
2.1 Reagents 
Glutathione-agarose resin, glutathione, DL-dithiothreitol (DTT), aminobenzylpenicillin 
(Ampicillin), thrombin from human plasma, sphingomyelin phosphodiesterase 
(Sphingomyelinase) and bovine serum albumin (BSA) were purchased from Sigma-
Aldrich (Oakville, ON). The BL 21 (DE3) strain of Escherichia coli was from Novagen 
(Madison, WI). The XL1 blue strain of Escherichia coli was attained from Clontech 
(Palo Alto, CA). pGEX-KG vector was a gift from Jingya Li (National Centre for Drug 
Screening, Shanghai, China). PWO DNA polymerase enzyme and deoxynucleoside 
triphosphates (dNTPs) were purchased from Roche (Mississauga, ON). Isopropyl β-
thiogalactoside (IPTG), ethylene diaminotetraacetic acid (EDTA) and Triton X-100 were 
received from Bioshop (Burlington, ON). Restriction endonucleases BglII, SpeI, SspI, 
HindIII, EcoRV, SalI, SnaBI, StyI, MunI, PvuII, Alw21I, BcivI, AlwNI, ScaI, Bsp1407I, 
PmaCI were from MBI Fermentas, as were the DNA marker and protein marker 
(Burlington, ON). PD-10 desalting columns were purchased from Amersham Biosciences 
(Baie D’Urfe, QC) and P-6DG desalting gel from BIO-RAD. Ethylenediamine (IANBD 
amide), Aamplexred cholesterol assay kit and sheep red blood cell were obtained from 
Cedarlane (Hornby, ON). β-Mercaptoethanol and dimethyformamide (DMF) were from 
EM SCIENCE (Gibbstown, NJ) and dimethyl sulphoxide (DMSO) from CALEDON. 
Plasmid DNA was prepared using QIAprep Spin Miniprep Kit from Qiagen (Mississauga, 




2.2 Plasmids and Bacterial Strains 
The plasmid pGEX-KG (61) containing the coding sequence of CAMP factor wild type 
and CAMP
M21L,M107L
 double mutant were used. The CAMP
M21L,M107L
 double mutant is 
active and for the purpose of this study equivalent to wild type CAMP factor. The coding 
sequence of these plasmids derived from wild type CAMP factor, amplified from 
Streptococcus agalactiae genomic DNA and matched the published mature peptide 
sequence for CAMP factor (53). All the mutagenesis was done in XL1 Blue E. coli. 
Transformations were done in a BioRad cell pulser electroporation unit according to the 
manufacturer’s instructions. Plasmids were purified using QIAprep Spin Miniprep Kit 
from Qiagen, according to the manufacturer’s instructions. All the wild type and mutant 
CAMP factor was expressed through BL21 (DE3) E. coli. 
 
2.3          Verification of Mutagenesis 
Residues from positions 90 to 115 were substituted individually for cysteine previously in 
the Palmer lab using a recombination based PCR protocol (54).  The PCR products were 
then transformed into competent XL-1 blue cells (Palo Alto, CA) and the now 
transformed cells plated on 100 µg/ml ampicillin agar plates and grown overnight at 37 
°C.  Single colonies on the plates were selected and grown in 10 ml LB (Luria-Bertani) 
(Bioshop) broth containing 100 µg/ml ampicillin.  The cells were then harvested and their 
DNA (plasmid) extracted.   The extracted plasmids were subsequently digested with 
restriction enzymes deliberately incorporated into the mutated plasmids for selection 
purposes.  After successfully identifying all the mutants, the plasmids were then 
transformed into competent BL21 (DE3) cells using electroporation and plated on 
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ampicillin agar plates.  The cells were then grown as before and the plasmids extracted 
using the QIAprep Spin Miniprep Kit Protocol (Qiagen).  Extracted plasmids were then 
sent to MOBIX lab, McMaster University, for sequencing.    
 
2.4 Preparation of Competent XL-1 blue Cells and their Transformation 
Fresh overnight XL-1 blue cells were inoculated into LB broth for a 1:100 dilution and 
grown at 37 
o
C to an optical density (OD600) of 0.4.  The cells were then spun at 3000 
rpm at 4 
o
C for 10 min after which the supernatant was decanted.  A 1 mL LB and 1 mL 2 
x TSS buffer were added to the cells and re-suspended gently on ice.  The now competent 
XL-1 blue cells were then aliquoted and stored at -70 
o
C until use.  To transform the cells, 
1 µL of plasmid DNA was added to 100 µL of thawed competent cells and incubated on 
ice for 45 min.  The cells were then heat shocked by placing the tubes in a 42 
o
C water 
bath for 45 sec.  The cells were then plated immediately on 100 µg/ml ampicillin agar 
plates.   
 
2.5 Preparation of Competent BL21 (DE3) Cells, and their transformation 
A high efficiency electro-transformation procedure was used to transform Escherichia 
coli BL21(DE3) (Novagen Madison, WI) cells from which protein synthesis was induced.  
A 1L L-Broth was inoculated with 10 mL of fresh overnight BL21(DE3) cell culture.  
These cells were grown at 37 
o
C with vigorous shaking to an OD600 of 0.6.  Cells were 
harvested by centrifuging at 4,000g for 15 min.  The supernatant was then removed and 
the pellet re-suspended in a total of 1liter of ice cold 10% glycerol.  Cells were then 
centrifuged as before, resuspended in 0.5, then 250 mL of 10% glycerol, centrifuged, then 
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re-suspended to a final volume of 4mL in ice cold 10% glycerol.  The re-suspended 
competent cells were aliquoted and stored at -80
  o
C.  To transform these competent cells, 
40 µL of the competent cells were mixed with 0.5 µL of plasmid DNA, mixed well and 
incubated on ice for 1min.  The E. coli pulser apparatus was set to 1.80 KV for a 0.1 cm 
cuvette.  The mixture of cells and plamid DNA were transferred to a cold electroporation 
cuvette, and the suspension was shaken to the bottom.  The cuvette was placed in a 
chilled safety chamber slide.  The slide was pushed into the chamber and pulsed once for 
every sample.  Immediately after pulsing, the cuvettes were removed from the chamber 
and their contents added to 1mL of SOC (2% Bacto tryptone, 0.5% Bacto yeast extract, 
10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM Mg SO4, 20 Mm glucose) medium to 
maximize the recovery of transformants.  The re-suspended cells were incubated for 1 
hour at 37 
o
C with vigorous shaking, 225 rpm.  Transformed cells were selected by 
plating on ampicillin agar plates.    
 
2.6 DNA Extraction 
To a micro-centrifuge tube, 1.5 mL of fresh overnight, mutant plasmid DNA transformed 
X-L1 Blue cells were added (55)  The cells were centrifuged at 10,000 g for 2 min and 
the supernatant aspirated.  The pellet was re-suspended in 100µL of solution 1 (50 mM 
glucose, 25 mM tris-HCl, Ph 8.0, 10 mM EDTA) and vortexed for 2 min.  The cells were 
incubated at room temperature for 5min for bacteria to be lysed and the DNA released. 
To these cells, 200 µL of solution II (0.2 M NaOH, 1% SDS) was added and mixed by 
inverting for 5 sec.  Finally, 150 µL of solution III (5 M potassium acetate) was added 
and mixed by inverting for 20 sec.  The contents of the tube were incubated on ice for 5 
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min for the plasmid DNA to be selectively renatured.  Following incubation, the tube was 
centrifuged at 12,000 g for 5 min and the supernatant containing the DNA was removed 
and placed in a new tube.  An equal volume of TE (10 mM Tris pH 7.5, 1 mM EDTA pH 
8.0)-saturated phenol-chloroform was then added to the DNA sample.  The DNA sample 
was vortexed vigorously for 20 sec followed by centrifugation at 15,000 g for 5 min to 
separate the phases.  The aqueous layer (DNA) was removed and added to a new tube 
after which an equal volume of chloroform : isoamyl alcohol (in a 24 : 1 ratio) was added.  
The steps of washing with chloroform, vortexing and centrifuging were repeated.  Finally, 
the DNA was ethanol precipitated by adding 1 mL of cold 100% ethanol, incubating on 
ice for 30 min, centrifuging at 15,000 g for 10 min and decanting the supernatant.  The 
pellet was washed with 70% ethanol, dried and re-suspended in TE buffer (56).  The 
extracted DNA was verified by running a 2 µL sample on a 1% agarose gel.  To extract 
DNA for sequencing, the Q1Aprep Spin Miniprep Kit Protocol (QIAGEN) was used. 
 
2.7 Protein Induction and Purification 
Protein induction and purification were performed according to published procedures (57) 
with minor variations.  An overnight 20 mL culture of BL21 (DE3) transformed cells was 
inoculated into 1 litre of 2XYT (liquid medium, 10 gram yeast extract, 16 gram tryptone, 
5 gram NaCl in 1 litre) (100 µg/ml Ampicillin) and grown at 37 o with shaking (250 to 
300 rpm), until an OD600 of 1 was reached.  Before inducing protein synthesis with 
isopropyl-β-D-thiogalactopyranoside (IPTG) (BioShop Canada Inc), 20 µL sample was 
removed and added to a 40 µL 1X SDS-PAGE
h
 (sodium dodecyl sulfate polyacrylamide 
gel electrophoresis) sample buffer.  Protein synthesis was then induced by adding IPTG 
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to a final concentration of 1 mM.  The culture was grown for another three hours, after 
which a second 20 µL sample was collected, and added to a 20 µL 1X SDS-PAGE 
sample buffer.  The samples were heated at 95 
 o
C for 5 min, loaded on a 12% SDS-
PAGE gel, and run at 200 V to verify induction of the protein. 
 Growth of E. coli, induction of protein synthesis, purification and thrombin 
cleavage of the recombinant protein was done essentially as described (55) with these 
deviations: Glutathione-agarose beads with the fusion protein adsorbed were washed 10 
times.  First 4 washes were done by 10 mL volumes of PBST buffer (16 mM K2HPO4, 
150 Mm NaCl, pH 7.2 1% triton X-100, 0.1% B-mercaptoethanol).   The next 4 washes 
were with 10 mL each PBS buffer (16 mM K2HPO4, 150 Mm NaCl, pH 7.2, 0.1% β-
Mercaptoethanol).  Finally, the column was washed twice with Thrombin cleavage buffer 
( 50 mM Tris (pH 8.0), 150 mM NaCl, 2.5 mM CaCl2, 2 mM DTT).  Following the 
numerous washing steps, 10 µg of thrombin was added to the column and the GST beads 
resuspended and incubated for one hour.  The purified protein was run on an SDS-PAGE 
gel to confirm the purity of the protein. 
 
2.8 Gel Filtration  
Gel filtration of solubilized CAMP factor protein was performed by passing the protein 
sample over a PD-10 (Amersham biosciences Baie D’Urfe QC) column (diameter: 
16mm : length 25cm) or Bio-Gel P-6DG (Bio-Rad Laboratories) desalting gel.  The 
column was equilibrated at room temperature with elution buffer (50 mM Tris pH 
7.5,150mM NaCl, 1 mM EDTA).  The CAMP protein was eluted with 3.5 mL of elution 
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buffer and collected in portions of 0.5 mL.  Eluate was checked for the presence of 
protein using the Bradford method (Coomassie brilliant blue G-250) for protein assay.  
 
2.9 Labeling of CAMP Factor Mutant Proteins with NBD  
 Following gel filtration (to remove any traces of β-mercaptoethanol or dithiothreitol 
(DTT) that might interfere with the labeling process) IANBD (NBD) (Cedarlane Hornby, 
ON) was added to a concentration that provided a 10-fold molar excess of reagent over 
the CAMP protein.  After 2 hours of incubation at room temperature, the reaction was 
quenched by the addition of DTT to 5 mM and the mixture filtered as before to separate 
labeled protein from excess NBD.  The fractions containing the NBD-labeled toxin were 
pooled, made 10% in glycerol, aliquoted, quick-frozen in liquid nitrogen, and stored at –
81
 o
C until they were used. Successful labeling and removal of excess dye was verified 
by illumination of the band, and also the absence of fluorescence at the dye-front 
respectively on UV-transilluminated SDS gel, data not shown. 
 
2.10 Hemolysis Assay 
The next step was to determine the effects of the cysteine substitutions and the 
addition of a bulky group such as the NBD on the activity of these mutants.  To this end, 
four hundred microliters of pelleted sheep erythrocytes (Cedarlane) were washed four 
times in Tris buffer (10 mM Tris-HCl, 150 mM NaCl, pH 7.4) by centrifugation. The 
erythrocytes were then resuspended in Tris buffer to 1% (v/v) (58). The cells were 
incubated at room temperature for 10 min with 10 mM MgCl2 and 50 milliunits/ml 
sphingomyelinase from Staphylococcus aureus (Sigma). Serial two-fold dilutions of 
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CAMP factor were prepared in a microtiter plate in the former buffer. Then, cell 
suspension was added to a final concentration of 0.5% or red blood cells in each well, and 
a starting toxin concentration of 3 µM. Hemolytic activity was measured by the decrease 
in turbidity (A650) using a 96-well plate reader (Spectramax 190, Molecular Devices, 
Sunnyvale, CA). Hemolytic titration was performed for all NBD-labeled and unlabeled 
mutant CAMP factor proteins; in each assay, the activity of the CAMP
M21L,M107L 
 mutant 
was measured as a control. 
 
2.11  Membrane Binding 
Four hundred milliliter of Bovine red blood cells was washed three times with PBS buffer, 
centrifuging at 2000 g for 4 min.  The red blood cells were then osmotically lysed by 
washing with lysis buffer (5 mM Na2HPO4, and 5 mM NaCl, pH 7) and centrifuging at 
14000 g for 10 min.  The pellet (red blood cell membranes) was re-suspended in 1 mL 
Tris buffer (50 mM tris pH 8, 150 mM NaCl) followed by the addition of 0.8 µL and 10 
µL MgCl2 (1M) and sphingomyelinase respectively.  The mixture was incubated at room 
temperature for one hour after which it was spun and washed once to remove residual 
sphingomyelinase; the supernatant from both centrifugation steps were discarded.  The 
sphingomyelinase treated red blood cells were then separated into 4, 250 µL portions, 
followed by the addition of the CAMP factor protein.  The red blood cell membranes-
CAMP factor mixture was incubated at room temperature for one hour to allow binding.  
Samples were then tested for membrane binding.  Samples were then centrifuged at 
14,000 g, supernatant collected, and washed once to remove unbound toxin.  The 
fluorescence of both the washed samples and supernatants were taken.    
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2.12 Spectrofluorimetry  
Emission spectra were recorded in a PTI Fluorescence Master System (excitation 
wavelength, 480 nm: emission wavelength 530 nm).  For each labeled mutant, samples of 
monomeric and membrane-bound CAMP proteins were examined.  After examining the 
membrane-protein samples, the samples were centrifuged and washed once to remove 
unbound toxin.  Supernatant and membrane-protein pellet were saved and their 
fluorescence emissions examined.  These extra steps were required to correct the 
fluorescence intensity of the membrane-bound toxin for incomplete toxin binding.  
 Corrections were done as follows: 
 
FImembrane, corrected = FImembrane pellet / (FImonomer - FIsupernatant)                                                  [2] 
 
The emissions from the membrane bound the monomer toxins were then compared to 
obtain the emission changes as a result of membrane binding. 
  
2.13 Cholesterol Assay 
To determine the lipid composition of the bovine red blood cell membranes, a cholesterol 
assay was run on the membranes using the Amplex Red Choesterol Assay Kit (Molecular 
Probes).  Briefly, The membrane samples were diluted in 1 X Reaction Buffer (20 mL of 
0.5 M potassium phosphate, pH 7.4, 0.25 M NaCl, 25 mM cholic acid, 0.5% Triton X-
100).  A positive control was prepared by diluting a 20 mM H2O2 working solution to 10 
µM in 1 X Reaction Buffer.  To separate microplate wells, 50 µL of the diluted 
membrane samples and the controls were added.  The reaction was initiated by adding 50 
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µL of the Amplex Red reagent containing horseradish peroxidase (HRP), cholesterol 
oxidase, cholesterol esterase to each microplate well containing the samples and control.  
The reaction was then incubated for 30 min at 37 
o
C protected from light.  The 
fluorescence was measured with the Plate Spectro Fluorimeter (Molecular Devices Corp, 
Spectra Max Gemini XS) fluorescence microplate reader with an excitation of 530 nm 
and emission at 590 nm.  The lipid concentration was found to be 1 mg/ml. 
 
2.14 Fluorescence Quenching with Hydrophobic Quenchers 
After the fluorescence emission of the membrane-toxin sample was recorded, the samples 
were spun down to separate bound toxin from unbound.  The supernatant from the 
centrifugation procedure was saved and its emission also recorded.  The membrane-toxin 
pellet was then resuspended in Tris buffer and the fluorescence measured.  Thereafter, the 
hydrophobic quencher, 5-doxyl-stearic acid was added to the membrane-toxin samples at 
increments of 0.05 µmol/mg lipid up to 0.25 µmol/mg lipid, taking the fluorescent 
reading after each addition.  A control sample containing only the membranes was also 
treated as above, and the successive stages subtracted from the corresponding samples.  
The data obtained from the quenching experiments were used to construct Stern-Volmer 
plots, the slopes of which were evaluated to determine the relative efficiency of 
quenching. The same procedure was also used for the 16-doxyl stearic acid quenching 





2.15 Time Resolved Fluorescence Measurements 
 Time-resolved fluorescence measurements were taken using the Fluo Time 100 
Compact Fluorescence Lifetime Spectrometer using the diode laser light source LDH-
P-C-470 (PicoQuant, Berlin, Germany).  Samples of NBD-labeled CAMP factor 
derivatives without membranes were excited in 1 cm x 1 cm quartz cuvettes in 50 mM 
Tris buffer, 150 mM NaCl, pH 8.  For samples containing membranes, the labeled toxin 
was added, incubated for 1 hour, and washed to remove any unbound toxin before 
obtaining the measurement.  Experimental decays were fit with three exponentials; 
allowing for a fourth component did not improve the goodness of the fits.  From these 
three components, an average lifetime for each sample was calculated using equation [1].  
 
  
<τ> = Σaiτi / Σai                                                                                                         [1] 
 









3.1 Construction of Mutants  
With the exceptions of mutants S101C, G110C, I111C, T112C, K113C, and 
V115C, which were constructed by Shanshan Liu, all mutants discussed below were 
constructed as part of this work.  All mutants were expressed as glutathione-S-transferase 
CAMP factor (GST-CAMP factor) fusion proteins.  Mutants were confirmed by 
restriction analysis and DNA sequencing and expressed in E. coli BL21 (DE3) cells.  
 
3.2 Purification of Mutants H95C to L114C 
Transformed cells were grown in rich media and protein expression induced. 
Purification of protein was successful with all mutants but three; the three exceptions 
were Q94C, A103C and L114C.  In the case of mutant A103C, no detectable protein 
synthesis was observed.  This lack of protein synthesis could be the result of an additional 
substitution mutation, T97A, in the amino acid sequence.  On the other hand, mutant 
L114C expresses the 52kDa fusion GST-CAMP factor protein when a sample of the 
induced culture is run on an SDS-PAGE gel.  After lysing the cells, however, the protein 
is lost in the pellet during centrifugation, which means that it is aggregated and possibly 
misfolded.  The purification procedure was repeated several times, each time changing 
parameters such as growing cells at lowered temperatures and keeping the harvested cells 
and cell lysate as close as possible to 4 °C.  These alterations to the purification 
procedure did not result in making the protein soluble.  As a result, L114C and A103C 
could not be purified and studied, and are not included in the data set generated.  In 
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contrast, the primers of mutant Q94C still needs to be designed and thus also not included 
in the data set. 
3.3 Production and IANBD Labeling of Cysteine Mutants 
 Mutants were labeled with the thiol-specific probe IANBD.  No reaction between 
IANBD and wild type was detected.  The extent of labeling was mutant-dependent and 
ranged from 20% (D106C) to 80% (F109C). These mutants were then assayed for 
hemolytic activity and binding to sphingomyelinase treated sheep red blood cells. Table 
3.1 shows a summary of the activities of the labeled and unlabeled mutants in comparison 
to the wild type toxin. 
CAMP Mutants Hemolytic Activity of NBD-
Labeled Mutants Compared to 
Unlabeled Mutants 
Hemolytic Activity of NBD-Labeled 
Mutants Compared to Wild-Type 
CAMP factor 
L96C Unchanged Reduced by factor of 2 
A97C Increased by factor of 2 Unchanged 
N98C Increased by factor of 2 Decreased by factor of 2 
K99C Increased by factor of 4 Decreased by factor of 16 
V100C Increased by factor of 4 Increased by factor of 2 
Q102C Increased by factor of 4 Unchanged 
N104C Increased by factor of 8 Decreased by factor of 4 
I105C Increased by factor of 2 Unchanged 
D106C Increased by factor of 2 Decreased by factor of 4 
L107C Increased by factor of 2 Unchanged 
G108C Increased by factor of 2 Decreased by factor 2 
F109C Unchanged Unchanged 
Table 3.1: Hemolytic activity of NBD-labeled CAMP factor compared to the un-labeled cysteine 
mutants and the wild type protein. 
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With the exceptions of mutant K99C, Q102C, N104C and D106C, all labeled mutants 
had activities comparable to that of the wild type toxin.  This hemolysis assay is meant as 
a control, to abolish any doubt of mutant activity.  The activity of these labeled mutants 
therefore suggests same behaviour on membranes.  Also, since the hemolysis assay tests 
limiting dilutions, it is not unlikely that even the mutants that perform sluggishly in the 
hemolysis assay react completely in the fluorescence assay since the fluorescence assays 
use higher concentrations of mutant toxins.   
 
3.4 Changes in NBD Environment Detected by Emission Fluorescence and 
Lifetime Measurements 
 
 Emission spectra were obtained for each monomeric NBD-labeled mutant in 
solution and when bound to sheep ghost membranes pretreated with sphingomyelinase.  
In solution, λmax from mutants H95C to F109C ranged from 531 (N104C) to 541 nm 
(F109C), indicating a relatively high degree of exposure of the NBD probe to the solvent 
(46). Mutant G108C however behaves differently; in solution, its emission maximum is 
at 526 nm, signifying a less polar environment.   
Upon interaction with sheep red blood cell membranes treated with 
sphingomyelinase, all mutants exhibited an increased intensity and a blue shift in NBD 
fluorescence indicating the change in the polarity of the NBD environment.  The mutant 
G108C retained its blue-shifted wavelength after membrane binding yet also exhibited an 
increase in NBD fluorescence, suggesting a more hydrophobic residence after membrane 
binding. Figure 3.1 shows example emission scans from mutants of adjacent residues, 
D106C and L107C in the monomeric and membrane-bound forms, showing the increase 
in intensity after membrane binding.  The increase in intensity after membrane binding 
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was observed for all tested mutants though to different extents (appendix A).  Figure 3.1C 
shows wavelength maxima of mutants from H95C to F109C.  Residues H95C to F109C 
for which the wavelengths are shown, the λmax were shifted to lower wavelengths by 
approximately 10 nm figure 3.1C. The values now range from 521 (N104C and F109C) 
to 534 nm (N98C).  This increase in intensity and blue shifts of all tested mutants indicate 
a transition to a hydrophobic environment by the NBD dye attached to the mutants.  Also 
apparent is a pattern in the wavelengths – notice the high and low blue shifts between 
N104C to F109C.  The deeply inserted residues show a more reduced wavelength.  Even 
more striking is the difference in wavelength between the membrane bound and 
monomeric mutants I105C, L107C and F109C.  These mutants show about a 20 nm 
difference in wavelength between the membrane-bound and monomeric forms, and are 
more blue-shifted than the other mutants.  This makes sense because the deeply inserted 

























































































Figure 3.1: Fluorescence intensity and emission maxima of NBD attached to cysteine-
substituted residues.  Emission scans of the soluble monomeric and membrane-bound 
forms of NBD-CAMP factor L107C (A) and NBD-CAMP factor D106C (B) are shown.  
C, wavelength maxima of soluble and membrane-bound mutants H95C to F109C.   
 
The combined fluorescence data for all residues within the region from T90C to 








































































Figure 3.2: A, Relative changes in the NBD emission intensity upon membrane binding 
of mutants T90C to V115C. B, Ratios of the excited state lifetimes of membrane-bound 




The change in the emission intensity of NBD was determined from the ratio of the 
fluorescence in the membrane-bound (Fmembrane) and soluble (Fsoluble) states. The intensity 
of the membrane-bound toxin was corrected for incomplete toxin binding as described in 
the methods section. The increased intensity upon membrane binding observed with most 
mutants indicates movement of the dye into a more hydrophobic environment.  Upon 
examination of figure 3.2A, specifically the region between residues N104C to F109C, 
one sees again an alternating pattern of low and high intensity changes.  To further 
characterize the behaviour of these residues within this region, we measured the 
fluorescence lifetimes of the labeled mutants before and after membrane binding. The 
lifetime of the excited state is an intrinsic property of the probe and therefore is not 
affected by sample concentration and is independent of relative standards. In addition, 
while the signal observed in steady-state fluorescence is an average value and may 
obscure heterogeneity in the sample (49), lifetime analysis has the potential to reveal the 
fractions of dye molecules in different environments.  If, on the other hand, the different 
signals observed in the steady-state spectra were truly characteristic of the protein and not 
caused by sample heterogeneity, a similar pattern should emerge from their lifetime 
measurements. 
Time-resolved measurements are widely used in fluorescence spectroscopy, 
particularly for studies of biological macromolecules (59).  This is because time-resolved 
data frequently contain more information than is available from the steady-state data (59).  
There are two methods of measuring time-resolved fluorescence: the time-domain and 
frequency domain.  
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For the purpose of this study, we will discuss the time-domain method.  In this 
method, the sample is excited with a pulse of light.  The width of the pulse is made as 
short as possible and is preferably much shorter than the decay time τ of the sample.  The 
time-dependent intensity is measured following the excitation pulse, and the decay time τ 
is calculated from the slope of a plot of log I(t) versus t. 
 Suppose a sample containing the fluorophore is excited with an infinitely sharp 
pulse of light.  This results in an initial population (no) of fluorophores in the excited state.  
The excited-state population decays with a rate Γ + knΓ according to  
 
dn(t)/dt = -(Γ+knr) n(t)                                                                                             [3] 
 
Where n(t) is the number of excited molecules at time t following excitation, Γ is the 
emissive rate, and knr is the non-radiative decay rate. Equation 3 states that both emission 
and non-radiative decay are random events, such that each excited fluorophore has the 
same probability of emitting or decaying non-radiatively in a given period of time.   
 In a fluorescence experiment we do not observe the number of excited molecules, 
but rather a fluorescence intensity, which is proportional to n(t).  Hence, Eq. [3] can also 
be written in terms of the time-dependent intensity I(t).  Integration of that form of Eq. [3] 
yields the expression for a single exponential decay 
 
I(t) = I0 e
-t/τ  
                                                                                                               [ 4] 
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where I0 is the intensity at time zero.  The lifetime τ is the inverse of the total decay rate: 
τ = 1/(Γ + knr).  
In general, the inverse of the lifetime is the sum of the rates that depopulate the excited 
state.  The fluorescence lifetime can be determined from the slope of a plot of log I(t) 
versus t (59).  If there is one lifetime, we will expect a single exponential decay and a 
straight line in the semi-logarithmic plot; if there are multiple lifetimes, the semi-log plot 






















Figure 3.3: Intensity decay measurement of mutant L107C.  Notice the curvature in the 
graph, indicative of a multi-exponential decay. 
 
Time-resolved measurements were performed for mutants labeled at residues 
N104C to F109C.  In every monomeric sample, the fluorescence lifetime data indicated 
the presence of three lifetime components table 3.2. The membrane-bound samples also 
display three different amplitudes with three different lifetimes: however, all lifetime 
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components of the membrane-bound samples are longer than those observed with the 
monomeric samples.  These three different lifetimes are not likely related to any property 
of the protein or to heterogeneous probe environments because the free dye itself also 
shows three lifetimes.  Therefore, the occurrence of multiple lifetimes is most likely a 
property of the dye.   
 
Free monomer Membrane-bound  
I0 Lifetime (ns) I0 Lifetime (ns) 
τ1 2753 4.603 14523 10.053 
τ2 15012 1.252 14807 4.258 
τ3 64064 0.489 12240 0.954 
τaverage 81829 0.77 41570  5.3 
 
Table 3.2: Fluorescence lifetime measurements of NBD-labeled monomeric and 
membrane-bound mutant L107C. 
 
A weighted average lifetime was calculated from these three different amplitudes 
and lifetimes using equation [1].  From this average, we see the monomeric mutants 
having an average lifetime of about 1ns, and about 5ns after membrane binding, 
signifying the movement of the dye into a hydrophobic environment.  When the ratios of 
the lifetimes between the membrane-bound and monomeric samples are taken, the same 
alternating pattern observed in the steady state and the blue shifts in wavelengths is 
apparent (figure 3.2 B).  More importantly, the residues that exhibited the highest in blue 
shifts are those residues that show the highest change in intensity and lifetimes.  
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3.5 Residues from T90 to K113 Insert Into the Membrane 
The location of the residues shown to enter a non-polar environment was 
confirmed by nitroxide quenching analysis.  Nitroxides are efficient quenching agents of 
NBD as previously shown by Chattopadhyay (60) and, when attached to the fatty acyl 
chain of stearic acid, nitroxides can be introduced into natural membranes and will only 
quench fluorophores exposed to the bilayer core (56). 
Fluorescence quenching refers to any process that decreases the fluorescence 
intensity of a sample (59).  A variety of molecular interactions can result in quenching.  
These include excited-state reactions, molecular rearrangements, energy transfer, ground-
state complex formation, and collisional or dynamic quenching (59).  In the case of 
collisional quenching, the quencher must diffuse to the fluorophore during the lifetime of 
the excited state.  Upon contact, the fluorophore returns to the ground state without 
emission of a photon (59).  For dynamic quenching to occur, the fluorophore and 
quencher must be in contact.  The requirement of molecular contact results in the 
numerous applications of quenching (59).  For example, quenching measurements can 
reveal the accessibility of fluorophores to quenchers (59). 
 Collisional quenching of fluorescence is described by the Stern-Volmer equation  
 
F0/F - 1 = kqτ0 [Q] = KD [Q]                                                                                [2] 
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In this equation, Fo and F are the fluorescence intensities in the absence and presence of 
quencher, respectively, kq is the bimolecular quenching constant, τo is the lifetime of the 
fluorophore in the absence of quencher, and [Q] is the concentration of quencher.  
Quenching data are usually presented as plots of Fo/F-1 versus [Q].  This is 
because Fo/F-1 is expected to be linearly dependent upon the concentration of quencher.  
A linear Stern-Volmer plot is generally indicative of a single class of fluorophores, all 
equally accessible to quencher.  If two fluorophore populations are present, and one class 
is not accessible to quencher, then the Stern-Volmer plots deviate from linearity toward 
the x-axis (59).  If the quenching is known to be dynamic, the Stern-Volmer constant 
(obtained as the slope of the plot) will be represented by KD and be equal to kqτo.  
Otherwise, this constant will be denoted as KSV. 
3.5.1 Quenching with 5-Doxyl Stearic Acid-The characteristics of this quencher 
is that its nitroxide moiety is positioned close to the surface of the membrane and so any 
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Figure 3.4: A diagram depicting 5-DSA within a phosphatidylcholine monolayer (which 
may be either the Trans or the Cis side of the membrane). 
 
 
Quenching data for NBD dyes positioned adjacent to each other in CAMP factor are 
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Figure 3.5: Stern-Volmer plots of mutants D106C and L107C quenched with 5 and 16-
Doxyl Stearic Acid.  Ksv represents the Stern-Volmer slope.  The higher degree of 
quenching of both mutants by 5 Doxyl Stearic Acid is reminiscent of the higher Ksv 
values.   
 
A linear Stern-Volmer plot as exhibited by most of these mutants is generally indicative 
of a single class of fluorophore, all equally accessible to quencher (59).  In the Stern-
Volmer plots, some of the mutants show deviations from linearity; this is most notable 
with mutant D106C.  It needs to be determined whether or not these deviations are 
systematic.  Figure 3.6 shows a summary of the pattern of quenching by 5-Doxyl Stearic 

























Figure 3.6: 5-Doxyl-stearic Acid Quenching pattern of NBD-labelled, membrane-bound 
mutants from residues H95C to F109C.  Plot is generated from the slopes of Stern-
Volmer plots.  Notice the alternating pattern between residues N104C to F109C. 
 
What we see in this figure is that there is quenching of all tested mutants as determined 
by their Stern-Volmer slopes, but the degree of quenching is dependent on the mutant.  
As with the lifetime and intensity change ratios, we again see the same alternating pattern 
of low and high quenching from residues N104C to F109C.   
3.5.2 Quenching with 16-Doxyl Stearic Acid-So, membrane inserted residues of 
the region of CAMP factor under study are quenched by a superficially residing quencher 
such as 5 doxyl stearic acid, but what will the results be when a quencher buried deeper 
in the membrane is employed? When the protein inserts into the membrane, individual 
residues may reside deeply or shallowly in the membrane.  So, by comparing the 
effectiveness of quenching by a superficially located quencher with a more deeply 
inserted one, we can get an idea about a residue’s depth of insertion.  We chose to 
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explore the quenching capabilities of 16-Doxyl Stearic acid on membrane-bound NBD-
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Figure 3.7: A diagram depicting the acyl chain with the nitroxide moiety attached at the 
16
th
 carbon.  This diagram is a representation of one leaflet of the bilayer.  So, this is 
either the Trans or the Cis side of the membrane. 
 
This lipophilic quencher has its nitroxide moiety located approximately in the middle of 
the bilayer and so should preferentially quench any labeled residues buried deep in the 
membrane core (figure 3.7).  As can be seen in figure 3.6 and 3.8, all labeled mutants 






























Figure 3.8: Comparison between 5 and 16 Doxyl Stearic Acid quenching of NBD-labeled 
CAMP factor mutants.  Notice the higher degree of quenching with 5 DSA as opposed to 
16 DSA.    
 
Interestingly, 16- and 5-doxyl stearic acid quench residues in the 90’s similarly compared 
to residues between N104C and F109C.  We also see the alternating pattern within 
residues N104C to F109C with the 16 doxyl stearic acid quenching, although mutant 
G108C breaks that pattern.  It is quenched more efficiently by 16- than by 5-doxyl stearic 
acid.  Nevertheless, this quenching assay suggests transition of the mutants into the 






These studies have demonstrated that upon CAMP factor binding and inserting 
into a membrane, the stretch of amino acids from T90C to K113C arranges into a 
conformation that inserts into the membrane.  More importantly, three different assays 
confirm that residues from N104C to F109C superficially insert into the membrane with a 
β-sheet conformation.  
 Typically, membrane insertion regions of pore-forming toxins are predicted from 
their monomer structures. This prediction is then confirmed by cysteine scanning 
mutagenesis.  In the present study, however, since the monomeric or oligomeric structure 
of CAMP factor is not yet known, a hydropathy plot of the protein was constructed - this 
gave a hydrophobic region that may likely be the membrane insertion region.  So, we 
studied this stretch of amino acids, from T90C to V115C, using cysteine scanning 
mutagenesis.  With several mutants, hemolytic activity was decreased by cysteine 
mutagenesis or covalent cysteine labeling, but all mutants retained significant activity and 
were therefore employed in the subsequent fluorescence studies.  
 Fluorescence intensity measurements of all mutants indicate that they change 
environment from a solvent exposed to a more hydrophobic one as indicated by their 
increase in intensity, figure 3.2 A.  This transition is also supported by the blue shifts 
mutants in this study exhibit, figure 3.1 C.  After membrane binding, all these mutants 
show a reduction in wavelengths by about 10 nm.  Subsequent quenching with 5- and 16-
doxyl stearic acid confirmed that this change in environment is a result of the dye, and 
thus the residues, moving into the hydrophobic core of the bilayer.  While mutants 
studied by Shanshan Liu also exhibit increased intensity, their shifts were not recorded, 
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but like mutants in this study, they do contact the membrane as they were quenched by 5-
- doxyl stearic acid. 
 Although all tested mutants were quenched by 5- and 16-doxyl stearic acid, they 
are quenched more so by 5- than 16-doxyl stearic acid.   When one examines figure 3.2 A, 
it is apparent that residues in the 90’s region are quenched to the same extent by 5- and 
16- doxyl stearic acid.  But from N104C to F109C, 5 doxyl stearic acid is more efficient.  
This suggests that residues in the 90’s insert deeper into the membrane.  For the residues 
to be quenched to the same extent by both quenchers, they would have to insert deep 
enough to collide with the deeply residing quencher, but shallow enough that they are 
also within the vicinity of the superficial quencher - perhaps halfway between both 
quenchers.  On the other hand, residues N104C to F109C are closer to the 5- doxyl group 
and so are quenched less by 16 doxyl stearic acid, implying a superficial residence. 
 Unlike the other residues, mutant G108C behaves anomalously; in solution, it has 
a wavelength of about 526 nm.  When bound to membrane, it retains this wavelength, 
suggesting hydrophobic residence before and after membrane binding, yet it exhibits 
intensity increase after membrane binding.  In the intensity difference, 5-doxyl stearic 
acid and lifetime assays, it is one of the alternating residues, behaving ideally and 
coherently with the pattern observed.  However, it is quenched more strongly by 16-
doxyl stearic acid and thus breaks the alternating pattern.  More tests would have to be 
done on this mutant to make conclusions or disprove this anomaly.    
Based on results from previously studied membrane damaging cytotoxins, 
membrane-inserting regions may adopt either α-structure or β-structure.  Membrane-
interactive amphipathic α-helices and β-strands are characterized by the periodicity of the 
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interaction of their side chains with the membrane and aqueous environments; 
approximately every 3.6 residues of an amphipathic α-helix interacts with the membrane 
(56), whereas alternating residues of an amphipathic β-strand interact with the membrane 
(49).   
When one examines figure 3.1 C, one notices that residues that form the 
alternating region, the residues that face the membrane core show about 20 nm blue shifts 
while those that will face the channel and thus be exposed to water show reductions of 
about 10 nm.  These same residues, those that face the membrane, show the highest 
change in intensity figure 3.2 A, and highest quenching figure 3.8.  To confirm this 
pattern, we chose to measure the lifetimes (reasons outlined in the results section) of the 
residues in this region. What we see after the lifetime measurements is the same 
alternating pattern within residues N104C to F109C.  In the work by Shatursky et al., (49) 
a similar alternating pattern was observed for a region of the toxin on which work was 
done. In this work however, while the hydrophobic resides that face the lipid membrane 
display a very high increase in intensity, the intervening hydrophilic residues show very 
little or no intensity increase at all.  The authors concluded that this alternating pattern 
reflects a β-sheet conformation, and that the corresponding sequence motif is the means 
by which this toxin, perfringolysin O, (PFO) penetrates the membrane.  Since this same 
pattern is observed in CAMP factor from residues N104C to F109C, we can also 
conclude that this region inserts with a β-sheet conformation.  However, in CAMP factor, 
both the hydrophobic and hydrophilic residues in the alternating region all exhibit 
intensity increase, with the hydrophobic residues having the highest change.  Given that 
the hydrophobic and hydrophilic residues all show some extent of intensity increase and 
 59
quenching with both 5- and 16-Doxyl stearic acid, the residence of this region is most 
likely that shown in figure 4.1     
 
Figure 4.1: Possible membrane interacting pattern of residues N104C to F109C of CAMP 
factor 
 
where the residues position themselves on the surface of the membrane in a β-sheet 
structure, thus, all residues having some extent of exposure to both quenchers.  The 
results of this study, together with the foregoing work by Shanshan Liu, represent the first 
characterization of a membrane-penetrating domain of CAMP factor. The possible role of 




















































































































































































































































































































































Appendix B, Stern-Volmer plots of 5 and 16 Doxyl Stearic Acid Quenched NBD  
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